11 Healthcare Stocks for Dividend Lovers

|
 |  Includes: ABT, AZN, GSK, JNJ, LLY, LZR, MRK, PFE, PMD, SHMR, VIVO
by: Insider Monkey

Healthcare is one of the fastest growing industries in the world. The annual growth rate of total expenditures on healthcare is 7.1% between 2000-2008 in the United States. Average annual growth in National Health Expenditures (NHE) for 2009 through 2019 is expected to be 6.3%. NHE as a share of Gross Domestic Product (GDP) is expected to be 19.6% by 2019.

We prepared a list of eleven Healthcare companies which pay fat dividend checks regularly. All companies in this list have a dividend yield of at least 3.5%. These eleven stocks returned 9.64% (including dividends) during the past 12 months, beating the government bonds by a large margin.

1- AstraZeneca PLC (NYSE:AZN): AstraZeneca is one of the leading biopharmaceutical companies in the world. AZN recently traded at $46.22 and has a 5.52% dividend yield. AZN gained 9.34% during the past 12 months. The stock has a market cap of $68 billion and P/E ratio of 8.3.

2- GlaxoSmithKline plc (NYSE:GSK): GlaxoSmithKline is one of the major drug manufacturers in the world. GSK recently traded at $37.62 and has a 5.42% dividend yield. GSK gained 2.73% during the past 12 months. The stock has a market cap of $97 billion and P/E ratio of 36.4. Warren Buffett has GSK in his portfolio.

3- Shamir Optical Industry, Ltd. (NASDAQ:SHMR): Shamir Optical Industry is a medical appliances and equipment company which is operating in Israel. SHMR recently traded at $13.85 and has a 5.81% dividend yield. SHMR gained 57.03% during the past 12 months. The stock has a market cap of $230 million and P/E ratio of 15.2.

4- Eli Lilly & Co. (NYSE:LLY): Eli Lilly is one of the major drug manufacturers in the world. LLY recently traded at $34.36 and has a 5.7% dividend yield. LLY gained 0.09% during the past 12 months. The stock has a market cap of $38 billion and P/E ratio of 7.5.

5- Psychemedics Corp. (NASDAQ:PMD): Psychemedics is providing testing services for the detection of abused substances in the United States. PMD recently traded at $9.3 and has a 5.16% dividend yield. PMD gained 25.85% during the past 12 months. The stock has a market cap of $45 million and P/E ratio of 17.9.

6- Emergent Group, Inc. (NYSEMKT:LZR): Emergent Group provides surgical equipment to hospitals, surgical care centers, and other health care providers in the United States. LZR recently traded at $8.45 and has a 4.74% dividend yield. LZR gained 13.12% during the past 12 months. The stock has a market cap of $58,2 million and P/E ratio of 18.8.

7- Merck & Co. Inc. (NYSE:MRK): Merck & Co., Inc., is a global health care company. MRK recently traded at $32.63 and has a 4.66% dividend yield. MRK lost 10.33% during the past 12 months. The stock has a market cap of $100 billion and P/E ratio of 116.5. David Tepper's Appaloosa has MRK in its portfolio.

8- Pfizer Inc. (NYSE:PFE): Pfizer is one of the leading biopharmaceutical companies in the world. PFE recently traded at $19.92 and has a 3.71% dividend yield. PFE gained 18.01% during the past 12 months. The stock has a market cap of $153 billion and P/E ratio of 19.5. Lee Ainslie's Maverick, David Einhorn's Greenlight, Curtis Schenker's Scoggin, and Roberto Mignone's Bridger have PFE in their portfolios.

9- Abbott Laboratories (NYSE:ABT): Abbott Laboratories is one of the major drug manufacturers in the world. ABT recently traded at $47.99 and has a 3.67% dividend yield. ABT lost 7.73% during the past 12 months. The stock has a market cap of $74 billion and P/E ratio of 16.2. Jim Simons has ABT in his portfolio.

10- Johnson & Johnson (NYSE:JNJ): Johnson & Johnson is one of the major drug manufacturers in the world. JNJ recently traded at $58.72 and has a 3.68% dividend yield. JNJ lost 5.99% during the past 12 months. The stock has a market cap of $166 billion and P/E ratio of 12.3. Warren Buffett, David Tepper, and Jim Simons have JNJ in their portfolio's.

11- Meridian Bioscience Inc. (NASDAQ:VIVO): Meridian Bioscience is an integrated life science company. VIVO recently traded at $21.37 and has a 3.56% dividend yield. VIVO gained 3.94% during the past 12 months. The stock has a market cap of $877 million and P/E ratio of 36.8.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.